Fort Sheridan Advisors LLC Has $507,000 Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Fort Sheridan Advisors LLC cut its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 6.8% in the fourth quarter, Holdings Channel reports. The fund owned 3,835 shares of the financial services provider’s stock after selling 279 shares during the period. Fort Sheridan Advisors LLC’s holdings in iShares Biotechnology ETF were worth $507,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in IBB. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF during the third quarter worth approximately $29,000. Highline Wealth Partners LLC bought a new position in iShares Biotechnology ETF in the 3rd quarter valued at $30,000. HHM Wealth Advisors LLC boosted its stake in iShares Biotechnology ETF by 200.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 150 shares in the last quarter. Bradley & Co. Private Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth $32,000. Finally, Newbridge Financial Services Group Inc. acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at $33,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 1.2 %

Shares of NASDAQ IBB opened at $135.46 on Friday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The firm’s 50-day simple moving average is $135.82 and its 200 day simple moving average is $140.68.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.